Daily FNArena News - Small Caps
All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure ChestLatest Stories
Brokers are excited about the growth prospects of rural transport and logistics company Lindsay Australia as it becomes the number one player in its industry
Sep 13 2023
Tim Boreham highlights a device used to detect pain in non-verbal patients, such as those suffering dementia and infants
Sep 11 2023
Tim Boreham shines a light on freshly listed Cleo Diagnostics, in search of an effective diagnostic tool for ovarian cancer
Aug 30 2023
Let’s talk about the unbreakable bond between households and their pets, and about the companies that offer exposure. Updated with today’s FY23 result release
Aug 28 2023
Previous Stories
Breaking Boundaries: Medical Psychedelics
Aug 21 2023
Australia is the first country in the world to legalise the use of psychedelic drugs for mental illness
Temple & Webster Spends Up For A Bigger Share
Aug 18 2023
Temple & Webster seems destined for strong growth, but at a lower margin as spending increases to grab more market share
USA Market Too Small For Overachieving Life360
Aug 17 2023
Expectations are on the rise for Life360 following second quarter results
Momentum Keeps Building For Avita Medical
Aug 15 2023
Brokers raise target prices for Avita Medical following second quarter results amidst anticipation of exciting prospects in the outlook period
Dr Boreham’s Crucible: IDT Australia
Aug 14 2023
Tim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis and psychedelic drug market
Stars Are Aligning For SiteMinder
Aug 02 2023
Analysts raise target prices for SiteMinder after management brings forward the time frame for being free cash flow positive
Dr Boreham’s Crucible: Telix Pharmaceuticals
Jul 31 2023
Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports
Syrah Resources: Near-Term Pain, Graphite Price Upside
Jul 20 2023
Analysts remain positive on Syrah Resources despite current weak market conditions for graphite
Dr Boreham’s Crucible: Arovella Therapeutics
Jul 17 2023
Tim Boreham highlights the potential for cancer treatment biotech Arovella Therapeutics
Dr Boreham’s Crucible: PolyNovo
Jul 06 2023
Skin repair specialist PolyNovo remains confident in its firm growth path ahead
